CLINICAL TRIALS PROFILE FOR TRIAMCINOLONE HEXACETONIDE
✉ Email this page to a colleague
All Clinical Trials for TRIAMCINOLONE HEXACETONIDE
| Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
|---|---|---|---|---|---|---|
| NCT00506896 ↗ | Monoarticular Corticosteroid Injection Versus Systemic Administration in the Treatment of Rheumatoid Arthritis Patients | Completed | Federal University of São Paulo | Phase 2 | 2004-07-01 | The purpose of this study is to compare the efficacy and safety of intra-articular glucocorticoid injection to its systemic use for treatment of knee synovitis in patients with Rheumatoid Arthritis |
| NCT00588354 ↗ | Epidural Clonidine for Lumbosacral Radiculopathy | Terminated | National Center for Research Resources (NCRR) | N/A | 2006-10-01 | This was a randomized, blinded study of transforaminal epidural injection of clonidine versus a similar injection of corticosteroid for acute lumbosacral radiculopathy. The hypothesis was that clonidine will be as effective as steroid for this condition. |
| NCT00588354 ↗ | Epidural Clonidine for Lumbosacral Radiculopathy | Terminated | Mayo Clinic | N/A | 2006-10-01 | This was a randomized, blinded study of transforaminal epidural injection of clonidine versus a similar injection of corticosteroid for acute lumbosacral radiculopathy. The hypothesis was that clonidine will be as effective as steroid for this condition. |
| NCT00660647 ↗ | Optimized Treatment Algorithm for Patients With Early Rheumatoid Arthritis (RA) | Completed | Aarhus University Hospital | Phase 3 | 2007-09-01 | Optimized treatment algorithm in early rheumatoid arthritis: Methotrexate and intra-articular glucocorticosteroid plus adalimumab or placebo in the treatment of early rheumatoid arthritis. A Randomised, double-blind and placebo-controlled, two arms, parallel group study of the additive effect of adalimumab concerning inflammatory control and inhibition of erosive development. Optimized Treatment Algorithms for Patients with Early RA |
| NCT00660647 ↗ | Optimized Treatment Algorithm for Patients With Early Rheumatoid Arthritis (RA) | Completed | Abbott | Phase 3 | 2007-09-01 | Optimized treatment algorithm in early rheumatoid arthritis: Methotrexate and intra-articular glucocorticosteroid plus adalimumab or placebo in the treatment of early rheumatoid arthritis. A Randomised, double-blind and placebo-controlled, two arms, parallel group study of the additive effect of adalimumab concerning inflammatory control and inhibition of erosive development. Optimized Treatment Algorithms for Patients with Early RA |
| NCT00660647 ↗ | Optimized Treatment Algorithm for Patients With Early Rheumatoid Arthritis (RA) | Completed | Meda Pharmaceuticals | Phase 3 | 2007-09-01 | Optimized treatment algorithm in early rheumatoid arthritis: Methotrexate and intra-articular glucocorticosteroid plus adalimumab or placebo in the treatment of early rheumatoid arthritis. A Randomised, double-blind and placebo-controlled, two arms, parallel group study of the additive effect of adalimumab concerning inflammatory control and inhibition of erosive development. Optimized Treatment Algorithms for Patients with Early RA |
| NCT00660647 ↗ | Optimized Treatment Algorithm for Patients With Early Rheumatoid Arthritis (RA) | Completed | University of Aarhus | Phase 3 | 2007-09-01 | Optimized treatment algorithm in early rheumatoid arthritis: Methotrexate and intra-articular glucocorticosteroid plus adalimumab or placebo in the treatment of early rheumatoid arthritis. A Randomised, double-blind and placebo-controlled, two arms, parallel group study of the additive effect of adalimumab concerning inflammatory control and inhibition of erosive development. Optimized Treatment Algorithms for Patients with Early RA |
| >Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for TRIAMCINOLONE HEXACETONIDE
Condition Name
Clinical Trial Locations for TRIAMCINOLONE HEXACETONIDE
Trials by Country
Clinical Trial Progress for TRIAMCINOLONE HEXACETONIDE
Clinical Trial Phase
Clinical Trial Sponsors for TRIAMCINOLONE HEXACETONIDE
Sponsor Name
